Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News Alert: HeartFlow announces plans to merge, go public in deal worth $2.4B

News You Need to Know Today
News Alert: HeartFlow announces plans to merge, go public in deal worth $2.4B
Friday, July 16, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

HeartFlow announces plans to merge, go public in deal worth $2.4B

Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”

READ MORE >
private equity corporatization business consolidation
Share on Twitter Share on Facebook Share on Linkedin

HeartFlow announces plans to merge, go public in deal worth $2.4B

Share on Twitter Share on Facebook Share on Linkedin
private equity corporatization business consolidation
Once the transaction is finalized, the combined entity will go by the name HeartFlow Group and be listed on the New York Stock Exchange as “HFLO.”
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

The biggest COVID-19 news in cardiology, all in one place
Key data from the 2020 Cardiovascular Leadership Survey | COVID-19 updates | Low-dose aspirin recommendations
Emergency cardiovascular care & COVID-19 | Statins reduce risk of developing HF from breast cancer therapies
Healthcare Economics & Policy | March 2020
4 coronavirus considerations | Hypertension-related death skyrockets | Covid-19 unkind to heart patients
What COVID-19 means for cath labs | Mental stress associated with repeat heart attacks | Cannabis & cardiology
Week in Review: Key COVID-19 updates | Stem cell therapy and heart attacks | Risk of death from stroke drops 24%

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …345
    • Page 346
    • Page 347
    • Page 348
    • Page 349
    • Page 350
    • Current page 351
    • Page 352
    • Page 353
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme